BRPI0511467A - método para inativar um vìrus contido em uma amostra - Google Patents

método para inativar um vìrus contido em uma amostra

Info

Publication number
BRPI0511467A
BRPI0511467A BRPI0511467-5A BRPI0511467A BRPI0511467A BR PI0511467 A BRPI0511467 A BR PI0511467A BR PI0511467 A BRPI0511467 A BR PI0511467A BR PI0511467 A BRPI0511467 A BR PI0511467A
Authority
BR
Brazil
Prior art keywords
sample
inactivate
virus contained
virus
treating
Prior art date
Application number
BRPI0511467-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Manfred Reiter
Wolfgang Mundt
Noel Barrett
Otfried Kistner
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of BRPI0511467A publication Critical patent/BRPI0511467A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0047—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M31/00—Means for providing, directing, scattering or concentrating light
    • C12M31/02—Means for providing, directing, scattering or concentrating light located outside the reactor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Sustainable Development (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BRPI0511467-5A 2004-05-27 2005-05-26 método para inativar um vìrus contido em uma amostra BRPI0511467A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57531004P 2004-05-27 2004-05-27
PCT/EP2005/005691 WO2005118000A1 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Publications (1)

Publication Number Publication Date
BRPI0511467A true BRPI0511467A (pt) 2007-12-26

Family

ID=34968615

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511467-5A BRPI0511467A (pt) 2004-05-27 2005-05-26 método para inativar um vìrus contido em uma amostra

Country Status (17)

Country Link
EP (1) EP1753470B1 (enExample)
JP (2) JP5502276B2 (enExample)
KR (1) KR101483337B1 (enExample)
CN (1) CN1956739B (enExample)
AU (1) AU2005249204B2 (enExample)
BR (1) BRPI0511467A (enExample)
CA (1) CA2567336C (enExample)
CR (1) CR8805A (enExample)
EA (1) EA010428B1 (enExample)
EC (1) ECSP067118A (enExample)
ES (1) ES2553457T3 (enExample)
IL (1) IL179262A (enExample)
MX (1) MXPA06013633A (enExample)
NO (1) NO20065912L (enExample)
NZ (1) NZ551857A (enExample)
WO (1) WO2005118000A1 (enExample)
ZA (1) ZA200610490B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118000A1 (en) * 2004-05-27 2005-12-15 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and uv light
GB0706507D0 (en) * 2007-04-03 2007-05-09 Medi Immune Ltd Protective device
ES2362990T5 (es) * 2007-06-15 2017-07-20 Amgen Inc. Métodos de tratamiento de medios de cultivo celular para su uso en un biorreactor
BR112012027643A2 (pt) * 2010-05-03 2016-08-16 Glaxosmithkline Biolog Sa métodos para a inativação de um orthomixovírus, para a preparação de uma vacina, e , composição imunogênica
JP5968795B2 (ja) * 2013-01-10 2016-08-10 四国化工機株式会社 紫外線殺菌装置
CN103992936B (zh) * 2014-04-22 2015-10-07 北京科兴生物制品有限公司 一种封闭式甲醛灭活病毒管道系统及其应用
US11771814B2 (en) 2018-07-27 2023-10-03 Terumo Bct Biotechnologies, Llc Flow cell
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
US20230256130A1 (en) 2020-07-27 2023-08-17 Riken Infection prevention device and infection prevention method
US12447225B2 (en) 2021-06-25 2025-10-21 University Of South Florida Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen
CN114229953B (zh) * 2021-12-25 2022-11-18 无锡诚源环境科技有限公司 腔体式紫外消毒器的紫外线剂量计算方法
GB2631765A (en) * 2023-07-13 2025-01-15 Univ Cranfield Viral inactivation reactor and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE10056096A1 (de) * 2000-11-13 2002-06-13 Bayer Ag Vorrichtung zur Bestrahlung von Flüssigkeiten
WO2005118000A1 (en) * 2004-05-27 2005-12-15 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Also Published As

Publication number Publication date
IL179262A (en) 2011-01-31
EP1753470A1 (en) 2007-02-21
NO20065912L (no) 2007-02-26
KR20110099810A (ko) 2011-09-08
AU2005249204A1 (en) 2005-12-15
ECSP067118A (enExample) 2007-02-28
JP2012143249A (ja) 2012-08-02
CR8805A (es) 2007-06-19
EA010428B1 (ru) 2008-08-29
JP2008500303A (ja) 2008-01-10
EA200602206A1 (ru) 2007-04-27
IL179262A0 (en) 2007-03-08
CN1956739A (zh) 2007-05-02
EP1753470B1 (en) 2015-08-19
JP5502276B2 (ja) 2014-05-28
CA2567336C (en) 2010-11-23
WO2005118000A1 (en) 2005-12-15
MXPA06013633A (es) 2007-03-23
KR101483337B1 (ko) 2015-01-15
CN1956739B (zh) 2011-12-28
CA2567336A1 (en) 2005-12-15
NZ551857A (en) 2009-11-27
HK1105374A1 (en) 2008-02-15
ZA200610490B (en) 2008-10-29
JP5675690B2 (ja) 2015-02-25
AU2005249204B2 (en) 2010-07-15
ES2553457T3 (es) 2015-12-09

Similar Documents

Publication Publication Date Title
BRPI0511467A (pt) método para inativar um vìrus contido em uma amostra
Rathnasinghe et al. The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
CY1121971T1 (el) Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας
CY1123684T1 (el) Θεραπευτικες συνθεσεις νουκλεασης και μεθοδοι
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
DK1596888T3 (da) Fremgangsmåde til den validerbare inaktivering af patogener i et biologisk fluidum ved bestråling
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
CY1120547T1 (el) Νανοσωματιδιο που περιλαμβανει ραπαμυκινη και αλβουμινη ως αντικαρκινικος παραγοντας
IL228065A0 (en) Live attenuated virus compositions, and methods for decreasing inactivation of live attenuated virus compositions
DK1943219T3 (da) 5-Lipoxygenase-aktiverende protein-(FLAP)-inhibitorer
CY1116019T1 (el) Μεθοδος χρησης καταστολεων histone deacetylase και παρακολουθηση παραγοντων βιο-σημανσης σε θεραπεια συνδυασμου
BRPI0814939A2 (pt) Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero.
CY1115299T1 (el) Αναστολεις mtor στη θεραπεια των ενδοκρινικων ογκων
BRPI0511834A (pt) métodos por tratar hepatite c
Freeman et al. Systematic evaluating and modeling of SARS-CoV-2 UVC disinfection
WO2006058062A3 (en) Blood irradiation system, associated devices and methods for irradiating blood
BRPI0807597A2 (pt) Composição farmacêutica, e, método para tratar infecção por vírus da influenza
DK2125174T3 (da) Fremgangsmåde og indretning til behandling af en væske
CL2010001634A1 (es) Compuestos derivados de nucleosidos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que los comprende; y combinacion farmaceutica.
UY32720A (es) Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados
EA201992617A1 (ru) Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
BRPI0612124A2 (pt) derivados de heteroarila para o tratamento de viroses
EP1958662A4 (en) LIGHT THERAPY PROCEDURE WITH A SEMICONDUCTOR LED AND LIGHT THERAPY SYSTEM WITH A SEMICONDUCTOR LED
BRPI0507645A (pt) anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: BAXTER INTERNATIONAL INC. (US) , BAXTER HEALTHCARE

Free format text: ENDERECO DO 2O DEPOSITANTE ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110115944/RJ DE 11/11/2011.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements